![Sjoerd Wadman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sjoerd Wadman
Directeur Technique/Scientifique/R&D chez
LanthioPep BV
Profil
Dr. Sjoerd Wadman is Vice President-Research & Development at LanthioPep BV and Vice President-Research & Development at Lanthio Pharma BV.
Dr. Wadman was previously employed as a Director-Therapeutic Projects by Novacta Biosystems Ltd., Project & Group Leader by Morphochem AG, and Project Leader by GlaxoSmithKline Plc.
He received his undergraduate degree from The University of Manchester and a doctorate degree from The University of Southampton.
Postes actifs de Sjoerd Wadman
| Sociétés | Poste | Début |
|---|---|---|
LanthioPep BV
 LanthioPep BV Medical SpecialtiesHealth Technology Specializes in in vivo stability of therapeutic and diagnostic imaging peptides | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Sjoerd Wadman
| Sociétés | Poste | Fin |
|---|---|---|
Novacta Biosystems Ltd.
 Novacta Biosystems Ltd. BiotechnologyHealth Technology Discovers and develops drugs for treatment of bacterial infections | Corporate Officer/Principal | 01/12/2011 |
Morphochem AG
 Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Corporate Officer/Principal | 01/01/2004 |
| GSK PLC | Corporate Officer/Principal | 01/12/2000 |
Lanthio Pharma BV
 Lanthio Pharma BV Medical SpecialtiesHealth Technology Focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics | Directeur Technique/Scientifique/R&D | - |
Formation de Sjoerd Wadman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Morphochem AG
Morphochem AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Commercial Services |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacta Biosystems Ltd.
Novacta Biosystems Ltd. BiotechnologyHealth Technology Discovers and develops drugs for treatment of bacterial infections | Health Technology |
LanthioPep BV
LanthioPep BV Medical SpecialtiesHealth Technology Specializes in in vivo stability of therapeutic and diagnostic imaging peptides | Health Technology |
Lanthio Pharma BV
Lanthio Pharma BV Medical SpecialtiesHealth Technology Focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics | Health Technology |
Choisissez Zonebourse 
